Zastaprazan Citrate

N/A

Report date: 2026/04/28 20:00:22
NME

Base Information

Drug NameZastaprazan Citrate
Drug Alias NameZastaprazanJAQBOJP-1366OCN-101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProton pump inhibitors
TargetsProton pump
Therapy Area/IndicationsHelicobacter pylori infectionDrug-Related Side Effects and Adverse ReactionsStomach Ulcer +[11] 
Global Approved IndicationsGastroesophageal Reflux
Approved Indications in ChinaN/A
Original Approved Country/TerritorySouth Korea
Original Approved Date2024/04/25
Country/TerritorySouth KoreaMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaNDA/BLA
Originator CompaniesJeil Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesLivzon Pharmaceutical Group IncJeil Pharmaceutical Co LtdOnconic Therapeutics Inc +[5] 
Inactive CompaniesN/A
Active IndicationsHelicobacter pylori infectionDrug-Related Side Effects and Adverse ReactionsStomach Ulcer +[9] 
Inactive IndicationsGastrointestinal DiseasesNeoplasms

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG